Nektar Therapeutics

Nektar Therapeutics

Clinical-stage biopharmaceutical company developing a pipeline of drug candidates. Learn more

Launch date
Employees
Market cap
AUD356m
Enterprise valuation
AUD110m (Public information from Sep 2024)
San Carlos California (HQ)
Authorizing premium user...